Sell Equitas Holdings, Ajanta Pharma; buy Ambuja Cements 270 Call: Mitessh Thakkar

Mitessh Thakkar of miteshthacker.com told CNBC-TV18, "We have been negative on Equitas Holdings last week as well and even now it presents a fresh selling opportunity. So keep a stop at about Rs 158.50-159 and Rs 144 is occurring over here. If Hindalco Industries breaks Rs 182-180 kind of support zone, that could possibly decline to levels of about Rs 165. So I would buy a Put option right now, if it breaks Rs 180, take a future short break."

"In Ambuja Cements, I would prefer the options route. So buying 270 Call or maybe even 260 Call can be a good idea. We have had a good gap up. The trend will extend for the next few days to come. The stock can hit Rs 280-285. So buying 270 Call can be a good idea, even 260 Call will be equally rewarding," he said.

"I had a sell on Ajanta Pharma. This declined a bit, if it gives an intraday bounce back around Rs 1,620, I would still suggest a sell with a stop loss at Rs 1,637 for target of around Rs 1,550. Havells India is a buy with a stop loss at Rs 485 and look for Rs 515 as the target."